Cancer Medicine, Radiology & Treatment

Mike Robinson is Director of Communications, American Academy of Cannabinoid Medicine, Cannabinoid Medicine Research Analyst. Few out of the world of medicinal cannabis have heard his inside story, a multiple cancer survivor who used cannabis oils extensively as well for severe epilepsy, chronic Lyme disease, PTSD, and in management. Over the last 5 years he has shared his journey and analytics on cannabinoid medicine research globally while assisting patients and clinicians during his own journey. An extensive background includes being an effective leader of a large cannabis compassion program providing to the disadvantages that treated countless medicinal cannabis consumers with various alternative protocol treatments. He is a published Journalist, Research Analyst, and former Chartered Accountant in State Lobbyist 1997, pro bono non-attorney representative for children with disabilities nationwide for over 2 decades, a member of the Board of Directors for Big Brothers and Sisters, the founder of multiple non-profits that advocate/advocated for the rights of disabled children.

The Potential for Liposomal Cannabinoids in the Treatment of Cytokine Response Syndrome

Dario Furnari is Ph.D. in Applied Biomedical Sciences in the neuroscience and traumatology and neuropharmacology sector. He is professor and consultant in neuroscience department

Neurobiology of aggression and violence

Natarajan Aravindan worked as Associate Professor, in Department of Radiation Oncology, Department of Anesthesiology, Department of Pathology Course Director, Radiation Biology for Radiation Oncology Residents and Graduate Faculty, College of Medicine. he is from University of Oklahoma Health Sciences Center

cancer radiology

Barbara DeVivo has spent her entire career in marketing management serving various executive global roles from market analysis and research, business development product management and professional relations. Ms. DeVivo has also amassed a strong proficiency in all facets of marketing management, sharing both academic and professional experiences. Currently, Ms. DeVivo is a PhD student at the State University of New York at Albany- Rockefeller College of Public Affairs and Policy whose research is centered on Organizational Behavior Management in Healthcare.

Organizational Behavior Management in Healthcare

Dimitrios H. Roukos, MD, PhD, is Professor of Surgery – Precision Cancer Medicine and Founding director of “Centre for Biosystems and Genome Network Medicine” in the Ioannina University, School of Medicine. Following conventional surgical oncology research, he has shifted into interpatient heterogeneity-based Personalized Cancer Medicine combining clinico-pathologic and single gene characteristics. Recently, he is exclusively focusing on intratumor multi-regional and even single-cell genetic, genomic, transcriptional and regulatory network heterogeneity-based drug resistance and relapse towards future clinical Precision Oncology. He has developed and published 3 breakthrough concepts to overcome clinical unmet needs. He has published > 240 PubMed papers, 36 on Precision Medicine and Oncology, and 80 on static and spatiotemporal genome analysis with NGS. These publications have received more than 9000 citations with h-index: 75 (Scopus). He is reviewer in many high impact journals including some with impact factor (IF) >30, evaluator in innovative research projects (EU, France, Italy, Belgium, Luxemburg, Poland), member in the editorial board of 25 international journals with IF, as well as Organizing Committee member and Invited lectures in > 130 International Conferences.

Precision Cancer Medicine,Cancer Diagnostics,Cancer Biomarkers

Claude Prigent has completed his PhD at the age of 30 years from Rennes University in France and postdoctoral studies from Imperial Cancer research Fund, Clare Hall Lab in London, UK. He is the director of research in the CNRS : National Center for Scientific Research in Freance. He has published more than 110 papers in reputed journals.

Cancer Cell Biology

Jana Slobodnikova. M.D., end study on Charles University in Prague., gradued - CSc / PhD / completed at the age 38 years from Institus of Experimental Oncology Slovac Scientic Academy. Ass. Prof. in 43 years from Trnaviensis University, Prof. emeritus at age 45 years from St. Elizabeth High Scool. I have lectured at several universities - Prague, Tren?ín, Trnava and Bratislava. I am the author of teaching script, university textbooks, I lead workshops, I organize international congresses and worksops Her has published more than 90 scientific papers, from then 25 papers in renomed journals and has been serving as an 5 editorial board member of repute. Her has published 3 monography, Her founded the Section of Breast Imaging in 1996, from 1996 her is president The Section of Breast Imaging of Slovak radiologic Society and vice president The Slovak Society of Ultrasound in Medicine. Membership in organizations : ECR, EUSOBI, EFSUMB , SSUM ( Slovak Society of Ultrasound in Medicine ) and SRS ( Slovak Radiology Society).

Radiology, Diagnosis of breast cancer, Screening, Radiology in oncology, Diagnosis and treatment of complications after breast spectrum of laboratory examination methods in Oncology, Tumor markers, Immunohistochemistry, biopsy surgery, treatment and diagnosis of lymphedema

Graduated from Toho Academy of Music in Tokyo, as a pianist and composer, invited by the Boston Symphony, she came to the USA in 1961 as one of the first Japanese women. She then received Master of Art from New York University and finished her Ph.D. credits in Philosophy in 1965. In 1967, Tatsumura then turned to an independent career and became the top International Classical and Cultural Impresario/producer. Until 1992, she produced an average of 2,000 cultural events each year, traveling to more than 140 countries. She was presented with numerous honors for her work from different countries, many for humanitarian causes. She is also well known as a philanthropist. She studied Oriental Traditional Medicine of Japan, Korea, Taiwan and China. In 2000 she received her PHD and OMD from the International Academy of Education in Tokyo. She established the Oki-Do Holistic Health Center in 1994 in NY and in 2001 the GAIA Holistic Center (501C3 nonprofit organization) at the wake of 9/11 tragedy, for body mind and spirit, aiming for the noninvasive natural healing methods based on the wisdom of the East.

She invented special holistic healing method called ONNETSU THERMOTHERAPY using Heat and 2 vibrations of Sun Far Infra-red (8-10μ) and Terahertz from deep earth planet minerals. The therapy has been widely hailed in hospitals and clinics especially in South Americas. Her invention is patent pending worldwide. “Overcoming Cancer and Other Diseases in a Holistic Way”, “Your Immune Revolution & Healing Your Healing Power”

Surgeon Paik was born in Iksan, Jeonbuk, Korea. He graduated from Seoul National University College of Medicine, ther after served as director of Korea Cancer Center Hospital, director of Konkuk University Medical Center, chairman of Korean Breast Cancer Society and chairman of Asia Breast Cancer Society. In 1986, he became the first surgeon to carry out breast-conserving surgery (BCS) in Korea. In 1991, he developed ‘Paik Nam-sun Stomach Cancer Surgery’ that reduces the risk of reflux oesophagitis. Such achievements earned him a spot on a list of the world’s top 100 gastric and breast cancer surgeons, unveiled by the international Biographical Center of Cambridge in the UK in 2006. He is unequivocally the No.1 breast cancer specialist in and outside Korea. 출처 : Korea IT Times(http://www.koreaittimes.com)

“The sufferings of breast cancer patients do not end after surgery. Breast cancer survivors, who had to have their breasts removed or disfigured, cannot go to public bathhouses or get divorced by their husbands. Their heartbreaking stories had prompted me to focus on breast-conserving surgery,” said breast cancer specialist Paik Nam-sun, Director of the Ewha Womans University Cancer Center for Women (hereafter EWUCCW).

Dr. Peifeng Li obtained his doctoral degree at the Chinese Academy of Medical Science. He worked as a medical researcher at the Max-Delbruck-Center for Molecular Medicine, Germany. He is currently the Dean of Institute of Translational Medicine, College of Medicine, University of Qingdao, China. His research focuses on the molecular regulation of cancers. He is a pioneer researcher in deciphering the role of microRNAs in cancers. He has published more than 170 papers in reputed journals and also presented his work at many national and international professional meetings. He is an associate editor of Frontiers in Physiology-Redox-Physiology, and Molecular Biotechnology. He has been a reviewer for more than 60 scientific journals.

Physiology-Redox-Physiology, and Molecular Biotechnology